Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports Second Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 44.51 -1.07 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.58 | 52 Week High | $24.79 | |||
| Open | $45.04 | 52 Week Low | $15.67 | |||
| Day High | $45.64 | P/E | N/A | |||
| Day Low | $43.92 | EPS | $-0.09 | |||
| Volume | 15,192,474 | |||||
| (NYSE: PEN) | Delayed: 323.56 -0.78 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $324.34 | 52 Week High | $79.49 | |||
| Open | $324.46 | 52 Week Low | $40.23 | |||
| Day High | $324.46 | P/E | N/A | |||
| Day Low | $321.97 | EPS | $0.00 | |||
| Volume | 377,650 | |||||



